Asunción: An anti-inflammatory drug, ordered and issued by the Social Security Institute IPS, appears to fight against other diseases, such as Alzheimer's disease.
The anti-inflammatory (Enbrel) pharmaceutical giant Pfizer could do the story: It's also a potent drug that can prevent Alzheimer's disease to 64%.
The surprising discovery took place in 2015, but the pharmaceutical company hid it because it was both expensive and difficult to validate.
The exclusive news was published by The Washington Post, citing sources referring to a group of researchers who confirmed the findings and kept them in the archives of the pharmaceutical company.
"Enbrel could potentially prevent, treat and slow the progression of Alzheimer's disease," says a Washington Post article written by the expert team of the Department of Inflammatory Drug Diseases.
Previous research on the treatment or prevention of Alzheimer's disease has been disappointing. It's hard to find anything that could help manage the incurable disease, at least until now. Alzheimer's disease affects half a million new patients each year worldwide
This is not the first time that drugs against certain types of diseases are very effective in curing or treating other diseases.
The pharmaceutical company Pfizer developed several decades ago Viagra (originally to fight against hypertension). However, this medication has proven to be an effective treatment against erectile dysfunction, a revolution to eradicate the male sexual problem in the elderly.
Not long ago, the Social Security Institute (IPS) asked, among other things, for the supply of Enbrel and made this medicine available to patients.
Weekly paper / Hoy
This service aims to increase the value of information and to establish a more fluid contact with readers. Comments need to be tailored about the article. Commentators are solely responsible for the content, which must be factual and clear. Insults and personal insults and racism will not be tolerated.